KCNH2 Variant L86R

Summary of observed carriers, functional annotations, and structural context for KCNH2 L86R. Data combine curated literature, international cohorts, and gnomAD observations.

Estimated LQT2 penetrance

59%

10/17 effective observations

Total carriers

7

7 LQT2 · 0 unaffected

Functional studies

3

Publications with functional data

L86R has not been reported in gnomAD. This residue resides in a Hotspot region for LQT2.

We have tested the trafficking efficiency of this variant: 0% of WT with a standard error of 0%. In our analysis we used SE < 20% as 'high quality'. Approximately below 50% of WT is considered PS3 moderate and below 30% is PS3 strong.

Variant features alone are equivalent to phenotyping 3 individuals with LQT2 and 7 unaffected individuals.

In silico predictors

Variant-level computational predictors.
PROVEAN PolyPhen-2 BLAST-PSSM REVEL Penetrance Density LQT2 (%)
-4.07 0.001 -3 0.898 79

PROVEAN scores below -2 suggest deleterious impact. REVEL scores above 0.5–0.75 are often interpreted as likely pathogenic. PolyPhen-2 scores above 0.85 are typically pathogenic. BLAST-PSSM reflects evolutionary conservation; more negative values indicate rarer substitutions. Penetrance density summarises neighbouring residue risk (Kroncke et al. 2019).

Reported carrier data

Observed carriers by publication or cohort.
Source Year Carriers Unaffected LQT2 Other Disease
11854117 2002 7 0 7
10973849 2000 1 0 1
Literature, cohort, and gnomAD – 7 0 7 –
Variant features alone – 10 7 3 –

Totals may differ from individual publications due to duplicate patients removed during curation.

Functional data

Functional assay results from published electrophysiology studies. Steady state (S.S.) and peak tail current are relative % to wildtype (100% being no different from wildtype). V1/2 activation and inactivation are the voltages at which half of the maximal current is reached, in mV. Recovery from inactivation and deactivation time are ratios of characteristic time constants with wildtype. HM indicates homomeric channels, HT indicates heteromeric channels.

Homomeric channel data

Published electrophysiology measurements (homomeric).
PubMed ID Cell Type S.S Peak (%WT) Peak Tail IKr (%WT) V1/2 Act. V1/2 Inact. Recov. Inact. Deactivation (%WT)
10187793 Xeno 1.7 9.0 None None
21536673 Xeno 0 None None None None
23721480 CHO None None None None

Heteromeric channel data

Published electrophysiology measurements (heteromeric).
PubMed ID Cell Type S.S Peak (%WT) Peak Tail IKr (%WT) V1/2 Act. V1/2 Inact. Deactivation (%WT)
10187793 Xeno None None None
21536673 Xeno None None None
23721480 CHO None None None

Nearby variants

Neighbouring residues within 15 Ångström provide structural context. Variants listed in the right-most column have been observed clinically or in gnomAD. Note that some residues appear multiple times at different distances since the functional KV11.1 channel (protein product of KCNH2/hERG) is a homotetramer and occasionally the same residue from multiple subunits is present within the 15Å window.

Previously observed variants near L86R.
Neighbour residue Distance (Å) Observed variants
86 0 L86R,
85 4 A85P, A85V,
87 5 L87P,
83 5 A83P, A83fsX,
125 6
88 7
82 7 I82Del, I82dup, I82Ins, I82T,
89 7 A89G, A89V,
64 7 C64R, C64Y,
84 7
112 8 V112M,
39 8 C39R, C39X,
90 8 E90K,
114 8 P114S,
65 9 T65P,
92 9 R92C, R92L,
122 9
34 9 A34T,
32 9 A32T,
127 10
80 10 A80P,
113 10 V113Del,
81 11 Q81E, Q81X, Q81P, Q81H, Q81H,
124 11 M124T, M124R,
126 11
33 11 N33T
38 11
63 11 P63H,
79 11 A79T, A79S, A79Del, A79fsX,
123 12
110 12 V110A,
40 12
115 12 V115M,
36 12 V36X,
94 12 V94L, V94L, V94A,
66 12 C66R, C66G, C66Y,
91 12
35 12 R35W,
111 12 D111V,
30 13 I30Del, I30T,
31 13 I31S,
121 13 A121fsX,
116 13 K116Q,
41 13 V41A,
78 13 A78T, A78P,
37 13
93 14 K93X, K93R,
67 14
128 15 N128S,
129 15 F129C,
42 15 I42N,